Mirum Pharmaceuticals (MIRM)'s 30-day implied volatility (IV30) was 44.5% at the close on November 9, 2026, down from 46.2% the day before, against a 52-week range of 23.8% to 101.8%. Its 20-day historical volatility was 53.8%.
Data as of November 9, 2026.